The stock market came off highs a bit, but the Nasdaq composite still led the way, up 1.2%, while gains in the Dow amounted ...
The Dow Jones index fell Tuesday on surprise Q3 GDP data. Novo stock soared on FDA approval for a weight loss pill.
The Dow rose 0.2% in premarket trading, as did S&P 500 futures. Futures on the tech-heavy Nasdaq 100 also moved up 0.2%.
The Dow Jones Industrial Average and other major indexes ended Friday's session higher as investors seemed satisfied with the September inflation results. SalesforceCRM was the biggest gainer on the ...